Streptococcus pneumoniae protein antigens (null)

Streptococcus pneumoniae protein antigens are a diverse group of surface-exposed or secreted proteins that are essential for the pathogenicity of the pneumococcus. Key antigens include Pneumolysin (Ply), a potent pore-forming toxin that damages host tissues and suppresses the immune response, and Pneumococcal surface protein A (PspA), which prevents complement-mediated opsonization. Other significant proteins include Pneumococcal surface adhesin A (PsaA) and Autolysin (LytA), which facilitate colonization and the release of inflammatory components, respectively (Kadioglu et al., 2008, Nature Reviews Microbiology). Unlike traditional polysaccharide-based vaccines that are serotype-specific, these protein antigens are often highly conserved across the species, making them primary targets for the development of next-generation, serotype-independent vaccines (Lagousi et al., 2019, Frontiers in Immunology). In therapeutic development, these proteins are targeted to elicit broad-spectrum protection by inducing antibodies that neutralize toxins or enhance the clearance of the bacteria by phagocytes. They are also being explored as targets for monoclonal antibody therapies to treat severe invasive pneumococcal disease where antibiotic resistance is a concern (Brooks-Walter et al., 1999, Infection and Immunity).

Other names

Pneumococcal protein antigensS. pneumoniae virulence factorsPneumococcal surface proteins

Induction of active immunity through B-cell and T-cell activation to promote opsonophagocytosis, neutralization of bacterial toxins, and inhibition of mucosal colonization.